Podcast: Syngene CEO On Sub-Dynamics As US Biotech Funding Finds New Normal, ADC Capabilities

 
• By Anju Ghangurde
Jonathan Hunt, MD & CEO, Syngene International • Source: Syngene

More from R&D

More from Scrip